Soretolide
Soretolide is an antiepileptic agent. Soretolide is effective in maximal electroshock-induced seizure (MES) test in rodents. Soretolide inhibits metabolism of Phenytoin. Soretolide exhibits a good pharmacokinetic character in rats model[1].
Product Specifications
CAS Number
130403-08-6
UNSPSC
12352005
Hazard Statement
H302-H315-H319
Target
Others
Type
Reference compound
Related Pathways
Others
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/soretolide.html
Solubility
10 mM in DMSO
Smiles
CC1=CC(NC(C2=C(C)C=CC=C2C)=O)=NO1
Molecular Formula
C13H14N2O2
Molecular Weight
230.26
Precautions
P264-P270-P280-P302+P352-P330-P362+P364-P501
References & Citations
[1]Luszczki JJ. Third-generation antiepileptic drugs: mechanisms of action, pharmacokinetics and interactions. Pharmacol Rep. 2009 Mar-Apr;61 (2) :197-216.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LC402435 20 µg
Pirh2 (RCHY1) (NM_015436) Human Over-expression Lysate
Sign In for Pricing
View Details